Published in J Ethnopharmacol on February 22, 2012
The quest for modernisation of traditional Chinese medicine. BMC Complement Altern Med (2013) 1.24
Network-based drug discovery by integrating systems biology and computational technologies. Brief Bioinform (2012) 1.09
Why is Research on Herbal Medicinal Products Important and How Can We Improve Its Quality? J Tradit Complement Med (2014) 1.02
21st century natural product research and drug development and traditional medicines. Nat Prod Rep (2013) 0.90
Untargeted metabolomics: an emerging approach to determine the composition of herbal products. Comput Struct Biotechnol J (2013) 0.86
Underestimating the toxicological challenges associated with the use of herbal medicinal products in developing countries. Biomed Res Int (2013) 0.83
An overview on adverse drug reactions to traditional Chinese medicines. Br J Clin Pharmacol (2015) 0.79
Effects of Tapinanthus globiferus and Zanthoxylum zanthoxyloides extracts on human leukocytes in vitro. J Intercult Ethnopharmacol (2014) 0.78
Biological activity and toxicity of the Chinese herb Magnolia officinalis Rehder & E. Wilson (Houpo) and its constituents. J Zhejiang Univ Sci B (2017) 0.75
Effects of Dietary Supplementation with Agaricus sylvaticus Schaeffer on Glycemia and Cholesterol after Streptozotocin-Induced Diabetes in Rats. Evid Based Complement Alternat Med (2014) 0.75
Structural Aspects of Antioxidant and Genotoxic Activities of Two Flavonoids Obtained from Ethanolic Extract of Combretum leprosum. Evid Based Complement Alternat Med (2016) 0.75
Quality control of herbal medicines. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 3.21
Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles. Chem Biol Interact (2013) 3.10
Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection. Crit Rev Toxicol (2007) 2.05
Nasopharyngeal carcinoma: the next challenges. Eur J Cancer (2010) 2.04
Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: patterns of failure. Oral Oncol (2012) 1.98
Salvage re-irradiation for recurrent head and neck cancer. Int J Radiat Oncol Biol Phys (2007) 1.91
Efficacy of antidepressants in treating the negative symptoms of chronic schizophrenia: meta-analysis. Br J Psychiatry (2010) 1.83
Cameroonian medicinal plants: pharmacology and derived natural products. Front Pharmacol (2010) 1.80
Chemotherapy-induced resistance by ATP-binding cassette transporter genes. Biochim Biophys Acta (2007) 1.79
An integrative approach of linking traditional Chinese medicine pattern classification and biomedicine diagnosis. J Ethnopharmacol (2011) 1.77
Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: a case series with 15-year follow-up. Am J Kidney Dis (2008) 1.71
Molecular principles of cancer invasion and metastasis (review). Int J Oncol (2009) 1.66
Progression rate of Chinese herb nephropathy: impact of Aristolochia fangchi ingested dose. Nephrol Dial Transplant (2002) 1.62
Syndrome differentiation in modern research of traditional Chinese medicine. J Ethnopharmacol (2012) 1.62
Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study. Int J Radiat Oncol Biol Phys (2007) 1.50
Evidence-based Chinese medicine for cancer therapy. J Ethnopharmacol (2007) 1.47
Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010. Arch Toxicol (2011) 1.46
Cytotoxicity of some Cameroonian spices and selected medicinal plant extracts. J Ethnopharmacol (2011) 1.46
Kudzu root: traditional uses and potential medicinal benefits in diabetes and cardiovascular diseases. J Ethnopharmacol (2011) 1.42
Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production. J Biol Chem (2010) 1.41
Response to letter to the editor with reference to article "Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: patterns of failure". Oral Oncol (2013) 1.40
Antimicrobial activity of clove and rosemary essential oils alone and in combination. Phytother Res (2007) 1.39
Cellular background level of 8-oxo-7,8-dihydro-2'-deoxyguanosine: an isotope based method to evaluate artefactual oxidation of DNA during its extraction and subsequent work-up. Carcinogenesis (2002) 1.36
A novel approach in discovering significant interactions from TCM patient prescription data. Int J Data Min Bioinform (2011) 1.34
Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers. Int J Radiat Oncol Biol Phys (2007) 1.33
Astragalus saponins induce growth inhibition and apoptosis in human colon cancer cells and tumor xenograft. Carcinogenesis (2006) 1.32
Microarray-based detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding cassette transporter genes. Cancer Res (2004) 1.32
Artesunate derived from traditional Chinese medicine induces DNA damage and repair. Cancer Res (2008) 1.31
Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung. Crit Rev Toxicol (2002) 1.28
Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate. Biochem Pharmacol (2004) 1.28
Modulation of human BCRP (ABCG2) activity by anti-HIV drugs. J Antimicrob Chemother (2007) 1.27
Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers. Int J Radiat Oncol Biol Phys (2008) 1.27
Development of high-performance liquid chromatographic fingerprints for distinguishing Chinese Angelica from related umbelliferae herbs. J Chromatogr A (2005) 1.26
The quest for modernisation of traditional Chinese medicine. BMC Complement Altern Med (2013) 1.24
Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation. Clin Infect Dis (2008) 1.23
Effect of clopidogrel and ticlopidine on cytochrome P450 2B6 activity as measured by bupropion hydroxylation. Clin Pharmacol Ther (2005) 1.22
Use of CpG island microarrays to identify colorectal tumors with a high degree of concurrent methylation. Methods (2002) 1.21
The natural compound n-butylidenephthalide derived from the volatile oil of Radix Angelica sinensis inhibits angiogenesis in vitro and in vivo. Angiogenesis (2011) 1.20
Antibacterial activity and anticancer activity of Rosmarinus officinalis L. essential oil compared to that of its main components. Molecules (2012) 1.20
A unique issue in the standardization of Chinese materia medica: processing. Planta Med (2010) 1.19
Artesunate in the treatment of metastatic uveal melanoma--first experiences. Oncol Rep (2005) 1.19
Schizophrenia and sudden cardiac death: a review. Nord J Psychiatry (2008) 1.19
Development and validation of the Chinese Quality of Life Instrument. Health Qual Life Outcomes (2005) 1.18
Naturally derived anti-inflammatory compounds from Chinese medicinal plants. J Ethnopharmacol (2012) 1.17
A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing - t4 report*. ALTEX (2012) 1.15
Electro-acupuncture in relieving labor pain. Evid Based Complement Alternat Med (2006) 1.15
The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo. Antiviral Res (2005) 1.14
Inhibition of cytochrome P450 2B6 activity by hormone replacement therapy and oral contraceptive as measured by bupropion hydroxylation. Clin Pharmacol Ther (2003) 1.14
Leishmaniasis: drug resistance and natural products (review). Int J Mol Med (2008) 1.13
Potentially prognostic miRNAs in HPV-associated oropharyngeal carcinoma. Clin Cancer Res (2013) 1.13
The role of Chinese medicine in the treatment of chronic diseases in China. Planta Med (2011) 1.13
Anticancer activities of six selected natural compounds of some Cameroonian medicinal plants. PLoS One (2011) 1.12
ABCA3 as a possible cause of drug resistance in childhood acute myeloid leukemia. Clin Cancer Res (2006) 1.11
Assay of free ferulic acid and total ferulic acid for quality assessment of Angelica sinensis. J Chromatogr A (2005) 1.10
Metabolic, nutritional, iatrogenic, and artifactual sources of urinary organic acids: a comprehensive table. Clin Chem (2002) 1.10
Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an "in vitro" replicative system. Antiviral Res (2005) 1.10
Treating gynaecological disorders with traditional Chinese medicine: a review. Afr J Tradit Complement Altern Med (2009) 1.10
Artesunate induces oxidative DNA damage, sustained DNA double-strand breaks, and the ATM/ATR damage response in cancer cells. Mol Cancer Ther (2011) 1.10
Antiviral effect of artemisinin from Artemisia annua against a model member of the Flaviviridae family, the bovine viral diarrhoea virus (BVDV). Planta Med (2006) 1.09
Polo-like kinase 1 as target for cancer therapy. Exp Hematol Oncol (2012) 1.09
Multiple P450 substrates in a single run: rapid and comprehensive in vitro interaction assay. Eur J Pharm Sci (2005) 1.09
Molecular biology of cantharidin in cancer cells. Chin Med (2007) 1.08
Mode of cell death induction by pharmacological vacuolar H+-ATPase (V-ATPase) inhibition. J Biol Chem (2012) 1.08
Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: current status and future perspective. J Ethnopharmacol (2012) 1.07
First evidence that the antimalarial drug artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases. Int J Cancer (2010) 1.07
Role of transferrin receptor and the ABC transporters ABCB6 and ABCB7 for resistance and differentiation of tumor cells towards artesunate. PLoS One (2007) 1.06
Traditionally used Thai medicinal plants: in vitro anti-inflammatory, anticancer and antioxidant activities. J Ethnopharmacol (2010) 1.06
The functional role of CYP2B6 in human drug metabolism: substrates and inhibitors in vitro, in vivo and in silico. Curr Drug Metab (2006) 1.06
Clinical studies with traditional Chinese medicine in the past decade and future research and development. Planta Med (2010) 1.06
Molecular interaction of artemisinin with translationally controlled tumor protein (TCTP) of Plasmodium falciparum. Biochem Pharmacol (2012) 1.05
Cytotoxicity and modes of action of four Cameroonian dietary spices ethno-medically used to treat cancers: Echinops giganteus, Xylopia aethiopica, Imperata cylindrica and Piper capense. J Ethnopharmacol (2013) 1.04
MicroRNA expression profile of MCF-7 human breast cancer cells and the effect of green tea polyphenon-60. Cancer Genomics Proteomics (2010) 1.04
Cytotoxicity of Thymus vulgaris essential oil towards human oral cavity squamous cell carcinoma. Anticancer Res (2011) 1.04
Pooling samples within microarray studies: a comparative analysis of rat liver transcription response to prototypical toxicants. Physiol Genomics (2005) 1.04
Selective inhibition of CYP2B6-catalyzed bupropion hydroxylation in human liver microsomes in vitro. Drug Metab Dispos (2004) 1.04
Shikonin directly targets mitochondria and causes mitochondrial dysfunction in cancer cells. Evid Based Complement Alternat Med (2012) 1.02
Cajanol, a novel anticancer agent from Pigeonpea [Cajanus cajan (L.) Millsp.] roots, induces apoptosis in human breast cancer cells through a ROS-mediated mitochondrial pathway. Chem Biol Interact (2010) 1.02
Good practice in reviewing and publishing studies on herbal medicine, with special emphasis on traditional Chinese medicine and Chinese materia medica. J Ethnopharmacol (2012) 1.02
Hypofractionated stereotactic radiotherapy using intensity-modulated radiotherapy in patients with one or two brain metastases. Stereotact Funct Neurosurg (2006) 1.02
Effect of artemisinins and other endoperoxides on nitric oxide-related signaling pathway in RAW 264.7 mouse macrophage cells. Nitric Oxide (2008) 1.02
Quality and safety of Chinese herbal medicines guided by a systems biology perspective. J Ethnopharmacol (2009) 1.01
Overweight and obesity negatively affect the outcomes of ovarian stimulation and in vitro fertilisation: a cohort study of 2628 Chinese women. Gynecol Endocrinol (2010) 1.01
Therapeutic and diagnostic applications of nanoparticles. Curr Drug Targets (2011) 1.00
Drug resistance in Plasmodium: natural products in the fight against malaria. Mini Rev Med Chem (2009) 1.00
Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles. Food Chem Toxicol (2013) 1.00
A sugar ester and an iridoid glycoside from Scrophularia ningpoensis. Phytochemistry (2005) 0.99
Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review). Int J Mol Med (2008) 0.98
In vitro interaction cocktail assay for nine major cytochrome P450 enzymes with 13 probe reactions and a single LC/MSMS run: analytical validation and testing with monoclonal anti-CYP antibodies. J Mass Spectrom (2007) 0.98
Pharmacogenomics of Cameroonian traditional herbal medicine for cancer therapy. J Ethnopharmacol (2011) 0.98
Effects of acupuncture on the outcomes of in vitro fertilization: a systematic review and meta-analysis. J Altern Complement Med (2012) 0.98
Expression profile of genes in non-small cell lung carcinomas from long-term surviving patients. Clin Cancer Res (2002) 0.97
Evaluation of the hepatotoxic and hepatoprotective effect of Rwandese herbal drugs on in vivo (guinea pigs barbiturate-induced sleeping time) and in vitro (rat precision-cut liver slices, PCLS) models. Exp Toxicol Pathol (2009) 0.97
First study of oral Artenimol-R in advanced cervical cancer: clinical benefit, tolerability and tumor markers. Anticancer Res (2011) 0.97
Future development of global regulations of Chinese herbal products. J Ethnopharmacol (2012) 0.96